The main problem is that most vector production technologies were developed for the lab, rather than to support industrial ...

Mirus offers solutions to increase process efficiency for viral vector production, and a unique reagent formulation that aims to boost virus quality and functional titres compared to traditional ...

Additionally, improving CAR-T biological efficiency could reduce dosing needs, further cutting costs and expanding access.

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

The combination of synchronous experimental process development and digital twin core model development is among the first of its kind.

The goal is to enhance the efficiency of inheritable germline mutations ... To achieve this, the team focused on two key aspects of CRISPR/Cas9 vector design: the promotor to drive Cas9 expression ...

Standardizing CAR T cell manufacturing is one of the key considerations for improving production standards, reducing variability, and maximizing clinical safety and efficacy. Download this article ...